HEADER CHOLINE-BINDING DOMAIN 15-MAR-05 2BML TITLE OFLOXACIN-LIKE ANTIBIOTICS INHIBIT PNEUMOCOCCAL CELL WALL DEGRADING TITLE 2 VIRULENCE FACTORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: AUTOLYSIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CHOLINE-BINDING DOMAIN, RESIDUES 193-318; COMPND 5 SYNONYM: N-ACETYLMURAMOYL-L-ALANINE AMIDASE, MUREIN, HYDROLASE, COMPND 6 MUCOPEPTIDE AMINOHYDROLASE, CELL WALL HYDROLASE; COMPND 7 EC: 3.5.1.28; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 1313; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: RB791; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PCE17 KEYWDS CHOLINE-BINDING DOMAIN, CELL WALL ATTACHMENT, OFLOXACIN-LIKE KEYWDS 2 ANTIBIOTICS EXPDTA X-RAY DIFFRACTION AUTHOR C.FERNANDEZ-TORNERO,G.GIMENEZ-GALLEGO,A.ROMERO,E.GARCIA,B.D.PASCUAL- AUTHOR 2 TERESA,R.LOPEZ REVDAT 4 13-DEC-23 2BML 1 REMARK REVDAT 3 24-FEB-09 2BML 1 VERSN REVDAT 2 19-MAY-05 2BML 1 JRNL REVDAT 1 30-MAR-05 2BML 0 JRNL AUTH C.FERNANDEZ-TORNERO,E.GARCIA,R.LOPEZ,B.D.PASCUAL-TERESA, JRNL AUTH 2 G.GIMENEZ-GALLEGO,A.ROMERO JRNL TITL OFLOXACIN-LIKE ANTIBIOTICS INHIBIT PNEUMOCOCCAL CELL JRNL TITL 2 WALL-DEGRADING VIRULENCE FACTORS JRNL REF J.BIOL.CHEM. V. 280 19948 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15769740 JRNL DOI 10.1074/JBC.M501236200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.FERNANDEZ-TORNERO,E.GARCIA,R.LOPEZ,G.GIMENEZ-GALLEGO, REMARK 1 AUTH 2 A.ROMERO REMARK 1 TITL A NOVEL SOLENOID FOLD IN THE CELL WALL ANCHORING DOMAIN OF REMARK 1 TITL 2 THE PNEUMOCOCCAL VIRULENCE FACTOR LYTA REMARK 1 REF NAT.STRUCT.BIOL. V. 8 1020 2001 REMARK 1 REFN ISSN 1072-8368 REMARK 1 PMID 11694890 REMARK 1 DOI 10.1038/NSB724 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 704892.210 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.4 REMARK 3 NUMBER OF REFLECTIONS : 9145 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.100 REMARK 3 FREE R VALUE TEST SET COUNT : 743 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.75 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1436 REMARK 3 BIN R VALUE (WORKING SET) : 0.3260 REMARK 3 BIN FREE R VALUE : 0.4120 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 135 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.035 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2108 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 108 REMARK 3 SOLVENT ATOMS : 55 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.61000 REMARK 3 B22 (A**2) : 9.60000 REMARK 3 B33 (A**2) : -3.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.35 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.49 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.430 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.490 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.690 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.600 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.68 REMARK 3 BSOL : 82.54 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : DEXTRO.PARAM REMARK 3 PARAMETER FILE 5 : PEGTRIS.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : DEXTRO.TOP REMARK 3 TOPOLOGY FILE 5 : PEGTRIS.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2BML COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-MAR-05. REMARK 100 THE DEPOSITION ID IS D_1290023345. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0163 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : TOROIDAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9193 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.1 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 20.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.27000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1HCX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE GROWN FROM A 12 MG/ML REMARK 280 PROTEIN SOLUTION OVER A WELL SOLUTION CONTAINING 2M AMMONIUM REMARK 280 SULPHATE AND 2% (W/V) PEG 400 BUFFERED WITH 0.1M HEPES (PH 7.5)., REMARK 280 PH 7.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 50.83500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.24000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 50.83500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.24000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 193 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 196 117.84 177.15 REMARK 500 LYS A 198 165.30 179.07 REMARK 500 ASP A 210 171.21 -49.44 REMARK 500 SER A 212 1.21 -160.94 REMARK 500 ALA A 245 44.85 72.21 REMARK 500 ASP A 246 -1.69 75.57 REMARK 500 LYS A 265 67.50 63.89 REMARK 500 LYS A 274 -76.04 -88.38 REMARK 500 ASN B 203 74.48 16.91 REMARK 500 ASP B 210 -172.07 -68.60 REMARK 500 ASP B 232 -177.63 -57.44 REMARK 500 ARG B 304 72.05 -118.18 REMARK 500 GLU B 310 -177.44 -65.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B1322 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B1323 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B1324 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS A1319 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS A1320 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P6G A1321 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XED B1319 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P6G B1320 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B1321 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GVM RELATED DB: PDB REMARK 900 CHOLINE BINDING DOMAIN OF THE MAJOR AUTOLYSIN (C-LYTA) FROM REMARK 900 STREPTOCOCCUS PNEUMONIAE REMARK 900 RELATED ID: 1H8G RELATED DB: PDB REMARK 900 C-TERMINAL DOMAIN OF THE MAJOR AUTOLYSIN ( C-LYTA) FROM REMARK 900 STREPTOCOCCUS PNEUMONIAE REMARK 900 RELATED ID: 1HCX RELATED DB: PDB REMARK 900 CHOLINE BINDING DOMAIN OF THE MAJOR AUTOLYSIN FROM STREPTOCOCCUS REMARK 900 PNEUMONIAE DBREF 2BML A 193 318 UNP P06653 ALYS_STRPN 193 318 DBREF 2BML B 193 318 UNP P06653 ALYS_STRPN 193 318 SEQADV 2BML ARG A 304 UNP P06653 LYS 304 CONFLICT SEQADV 2BML ARG B 304 UNP P06653 LYS 304 CONFLICT SEQRES 1 A 126 SER TYR PRO LYS ASP LYS PHE GLU LYS ILE ASN GLY THR SEQRES 2 A 126 TRP TYR TYR PHE ASP SER SER GLY TYR MET LEU ALA ASP SEQRES 3 A 126 ARG TRP ARG LYS HIS THR ASP GLY ASN TRP TYR TRP PHE SEQRES 4 A 126 ASP ASN SER GLY GLU MET ALA THR GLY TRP LYS LYS ILE SEQRES 5 A 126 ALA ASP LYS TRP TYR TYR PHE ASN GLU GLU GLY ALA MET SEQRES 6 A 126 LYS THR GLY TRP VAL LYS TYR LYS ASP THR TRP TYR TYR SEQRES 7 A 126 LEU ASP ALA LYS GLU GLY ALA MET VAL SER ASN ALA PHE SEQRES 8 A 126 ILE GLN SER ALA ASP GLY THR GLY TRP TYR TYR LEU LYS SEQRES 9 A 126 PRO ASP GLY THR LEU ALA ASP ARG PRO GLU PHE THR VAL SEQRES 10 A 126 GLU PRO ASP GLY LEU ILE THR VAL LYS SEQRES 1 B 126 SER TYR PRO LYS ASP LYS PHE GLU LYS ILE ASN GLY THR SEQRES 2 B 126 TRP TYR TYR PHE ASP SER SER GLY TYR MET LEU ALA ASP SEQRES 3 B 126 ARG TRP ARG LYS HIS THR ASP GLY ASN TRP TYR TRP PHE SEQRES 4 B 126 ASP ASN SER GLY GLU MET ALA THR GLY TRP LYS LYS ILE SEQRES 5 B 126 ALA ASP LYS TRP TYR TYR PHE ASN GLU GLU GLY ALA MET SEQRES 6 B 126 LYS THR GLY TRP VAL LYS TYR LYS ASP THR TRP TYR TYR SEQRES 7 B 126 LEU ASP ALA LYS GLU GLY ALA MET VAL SER ASN ALA PHE SEQRES 8 B 126 ILE GLN SER ALA ASP GLY THR GLY TRP TYR TYR LEU LYS SEQRES 9 B 126 PRO ASP GLY THR LEU ALA ASP ARG PRO GLU PHE THR VAL SEQRES 10 B 126 GLU PRO ASP GLY LEU ILE THR VAL LYS HET TRS A1319 8 HET TRS A1320 8 HET P6G A1321 19 HET XED B1319 26 HET P6G B1320 19 HET PG4 B1321 13 HET SO4 B1322 5 HET SO4 B1323 5 HET SO4 B1324 5 HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETNAM P6G HEXAETHYLENE GLYCOL HETNAM XED DEXTROFLOXACINE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM SO4 SULFATE ION HETSYN TRS TRIS BUFFER HETSYN P6G POLYETHYLENE GLYCOL PEG400 FORMUL 3 TRS 2(C4 H12 N O3 1+) FORMUL 5 P6G 2(C12 H26 O7) FORMUL 6 XED C18 H20 F N3 O4 FORMUL 8 PG4 C8 H18 O5 FORMUL 9 SO4 3(O4 S 2-) FORMUL 12 HOH *55(H2 O) SHEET 1 AA 2 LYS A 198 ILE A 202 0 SHEET 2 AA 2 THR A 205 PHE A 209 -1 O THR A 205 N ILE A 202 SHEET 1 AB 2 ARG A 219 LYS A 222 0 SHEET 2 AB 2 TRP A 228 PHE A 231 -1 O TYR A 229 N ARG A 221 SHEET 1 AC 2 GLY A 240 LYS A 243 0 SHEET 2 AC 2 TRP A 248 PHE A 251 -1 O TYR A 249 N LYS A 242 SHEET 1 AD 2 GLY A 260 LYS A 263 0 SHEET 2 AD 2 TRP A 268 LEU A 271 -1 O TYR A 269 N VAL A 262 SHEET 1 AE 2 ALA A 282 GLN A 285 0 SHEET 2 AE 2 TRP A 292 LEU A 295 -1 O TYR A 293 N ILE A 284 SHEET 1 AF 2 PHE A 307 VAL A 309 0 SHEET 2 AF 2 ILE A 315 VAL A 317 -1 O THR A 316 N THR A 308 SHEET 1 BA 2 LYS B 198 ILE B 202 0 SHEET 2 BA 2 THR B 205 PHE B 209 -1 O THR B 205 N ILE B 202 SHEET 1 BB 2 ARG B 219 LYS B 222 0 SHEET 2 BB 2 TRP B 228 PHE B 231 -1 O TYR B 229 N ARG B 221 SHEET 1 BC 2 GLY B 240 LYS B 243 0 SHEET 2 BC 2 TRP B 248 PHE B 251 -1 O TYR B 249 N LYS B 242 SHEET 1 BD 2 GLY B 260 TYR B 264 0 SHEET 2 BD 2 THR B 267 LEU B 271 -1 O THR B 267 N TYR B 264 SHEET 1 BE 2 ALA B 282 GLN B 285 0 SHEET 2 BE 2 TRP B 292 LEU B 295 -1 O TYR B 293 N ILE B 284 SHEET 1 BF 2 PHE B 307 VAL B 309 0 SHEET 2 BF 2 ILE B 315 VAL B 317 -1 O THR B 316 N THR B 308 SITE 1 AC1 9 LYS A 201 TRP A 206 LYS B 243 TRP B 248 SITE 2 AC1 9 P6G B1320 HOH B2028 HOH B2033 HOH B2034 SITE 3 AC1 9 HOH B2035 SITE 1 AC2 4 LYS A 243 TRP A 248 LYS B 201 TRP B 206 SITE 1 AC3 3 GLN A 285 ASN B 281 HOH B2036 SITE 1 AC4 2 TRP A 220 GLU A 275 SITE 1 AC5 4 TRP A 261 TRP A 268 TYR A 293 LEU A 301 SITE 1 AC6 5 TRP A 241 TRP A 248 TYR A 269 MET A 278 SITE 2 AC6 5 ASP A 298 SITE 1 AC7 8 SER B 212 GLY B 213 TYR B 214 MET B 215 SITE 2 AC7 8 TRP B 220 TRP B 228 GLU B 275 HOH B2009 SITE 1 AC8 11 PHE A 199 TRP A 206 TYR A 229 GLU A 254 SITE 2 AC8 11 TRP B 241 TRP B 248 TYR B 264 TYR B 269 SITE 3 AC8 11 ASP B 298 SO4 B1322 HOH B2030 SITE 1 AC9 5 TYR A 207 MET A 215 TRP B 261 TRP B 268 SITE 2 AC9 5 HOH B2032 CRYST1 101.670 94.480 38.100 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009836 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010584 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026247 0.00000 MTRIX1 1 -0.954470 0.298180 0.008920 59.54821 1 MTRIX2 1 0.278340 0.900920 -0.332990 -3.80160 1 MTRIX3 1 -0.107330 -0.315340 -0.942890 30.12691 1